Mount Sinai Logo

Robert Phillips

Print ProfilePrint Profile


  • MD, Mount Sinai School of Medicine

  • Columbia-Presbyterian Medical Ctr.

  • Columbia-Presbyterian Medical Ctr.

  • Mount Sinai Medical Center

  • Mount Sinai Medical Center


    Clinical Interest
    Hypertension, coronary artery disease, valvular heart disease

    Specialty: Cardiology

    Board Certification
    Am Board of Internal Medicine (Int Med)
    Am Board of Internal Medicine (Sub: Cardv Disease)


Phillips RA, Krakoff LR, Finegood DT, Dunaif A. Hemodynamic and humoral correlates of insulin resistance in non-obese borderline hypertensives: A . Blood Press 1996; 5(Suppl 1): 72-74.

Gharavi A, Lipkowitz MS, Diamond J, Jhang JS, Phillips RA. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in sys. Am J Cardiol 1996; 77: 1315-1319.

Gharavi A, Phillips RA, Finegood DT, Lipkowitz MS. Glycogen synthase polymorphism and insulin resistance in hypertension. Blood Press 1996; 5: 86-90.

Ramakrishna G, Schechter C, Phillips RA. Diagnosis and treatment of isolated systolic hypertension (ISH) in the elderly: Results of a study four years post SHEP. Am J Geri Cardiol 1997;: 20-36.

Jhang J, Diamond J, Phillips RA. Interobserver variability of left ventricular measurements in a population of predominantly obese hypertensives using simultaneously acquired and disp. Echocardiography 1997; 14: 9-14.

Diamond J, Krakoff LR, Martin K, Wallenstein S, Phillips RA. Comparison of ambulatory blood pressure and amounts of left ventricular hypertrophy in men vs. women with similar levels of hypertensive clinic blood . Am J Cardiol 1997; 79: 506-508.

Gharavi A, Lipkowitz ML, Diamond J, Chamie R, Travis AR, Phillips RA. elationship of angiotensinogen polymorphism with office and ambulatory blood pressure. Am J Hypertens 1997; 10: 687-691.

Moore C, Krakoff LR, Phillips RA. Confirmation or exclusion of stage I hypertension by ambulatory blood pressure monitoring. Hypertension 1997; 29: 1109-1113.

Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S. Relation of left ventricular mass to insulin resistance and blood pressure in non-obese subjects. J Clin Endocrinol Metab 1998; 83(12): 4284-4288.

Gharavi A, Diamond J, Phillips RA. Resting diastolic function and left ventricular mass are related to exercise capacity in hypertensive men but not in women. Am J Hypertens 1998; 11: 1252-1257.

Shussheim A, Diamond J, Jhang J, Phillips RA. Midwall fractional shortening is an independent predictor of diastolic dysfunction in patients with systemic hypertension . Am J Cardiol 1998; 82: 1056-1059.

Diamond J, Gharavi A, Roychoudhury D, Travis A, Henzlova M, Machac J, Phillips RA. Effect of long-term eprosartan vs. enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Curr Med Res Opin 1999; 15(1): 1-8.

Loeb ED, Diamond J, Krakoff LR, Phillips RA. Real versus apparent gender differences in blood pressure response to calcium channel blockade in the treatment of moderate to severe hypertension. Blood Press Monit 1999; 4: 209-212.

Herbert R, Schacter C, Phillips RA. Occupational coronary heart disease among bridge and tunnel officers. Arch Environ Health 2000;.

Olsen MH, Fossum E, Hjerkinn E, Wachtell K, Hoeiggen A, Nesbitt SD, Anderson UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S. Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub-study. J Hypertens 2000; 18: 1-7.

Butkevich A, Phillips RA, Sheinart KA, Tuhrim S. The effect of different definitons of dipping and ay and nighttime on the characterization of 24-hour blood pressure profiles. Blood Press Monit 2000;.

Vagaonescu TB, Saadia B, Tuhrim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patient with primary autonomic failure. Lancet 2000;.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Phillips is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central